Therapeutic area
Cardiometabolic Disease
Diseases of metabolism and the cardiovascular system, including obesity, diabetes, and their shared comorbidities.
Diseases
Chronic Kidney Disease
$646.5B attributable cost
$50.3B drug spend
98 assets · 1 indication
MASH / NASH
$303.2B attributable cost
$1.0B drug spend
30 assets · 1 indication
Obesity
$199.1B attributable cost
$10.6B drug spend
120 assets · 1 indication
Type 2 Diabetes
$324.6B attributable cost
$126.1B drug spend
128 assets · 1 indication